The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Elevated Plasma Level of Visfatin/Pre-B Cell Colony-Enhancing Factor in Patients with Type 2 Diabetes Mellitus
Abstract
CONTEXT: Visfatin (also known as pre-B cell colony-enhancing factor or PBEF) is a cytokine that is highly expressed in visceral fat and whose blood levels correlate with obesity. Originally isolated as a secreted factor that promotes the growth of B cell precursors and recently found to act as an insulin analog on the insulin receptor, its pathophysiological role in humans remains largely unknown. OBJECTIVES: In this study we investigated whether plasma visfatin level is altered in patients with type 2 diabetes mellitus (T2DM). DESIGN AND PATIENTS: Plasma visfatin as well as adiponectin and resistin concentrations were measured through ELISA in type 2 diabetic and nondiabetic subjects. RESULTS: A total of 61 patients with T2DM and 59 sex- and age-matched nondiabetic subjects were studied. Plasma visfatin was found to be elevated in patients with T2DM (31.9 +/- 31.7 vs. 15.8 +/- 16.7 ng/ml, P = 0.002). In contrast, adiponectin was decreased (4.3 +/- 2.5 vs. 30.8 +/- 10.3 microg/ml, P < 0.001), whereas plasma resistin level did not differ between the groups. Increasing concentrations of visfatin were independently and significantly associated with T2DM. Multiple logistic regression analysis revealed visfatin as an independent association factor for T2DM, even after full adjustment of known biomarkers. The association between adiponectin and T2DM was no longer significant after adjustments for body mass index or waist to hip ratio. In a multiple linear regression analysis, only waist to hip ratio was independently associated with plasma visfatin level. CONCLUSION: Our results indicate that visfatin may play a role in the pathogenesis of T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedMatthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
Adipose tissue, adipokines, and inflammation
Fantuzzi, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.023 · Cited by 2,606
Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.
Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S., & McNiece, I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1431 · Cited by 1,019
Regulation of Fasted Blood Glucose by Resistin
Banerjee, R. R., Rangwala, S. M., Shapiro, J. S., Rich, A. S., Rhoades, B., Qi, Y., Wang, J., Rajala, M. W., Pocai, A., Scherer, P. E., et al. (2004) · Science · doi:10.1126/science.1092341 · Cited by 725
Jia, S. H., Li, Y., Parodo, J., Kapus, A., Fan, L., Rotstein, O. D., & Marshall, J. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19930 · Cited by 598
Cited by
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties
Moschen, A. R., Kaser, A., Enrich, B., Mosheimer, B., Theurl, M., Niederegger, H., & Tilg, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1748 · Cited by 933
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865
Adipokines and Insulin Resistance
Rabe, K., Lehrke, M., Parhofer, K. G., & Broedl, U. C. (2008) · Molecular Medicine · doi:10.2119/2008-00058.rabe · Cited by 808
Adipocytokines and the Metabolic Complications of Obesity
Rasouli, N., & Kern, P. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1613 · Cited by 743
Adipokines: The missing link between insulin resistance and obesity
Antuna-Puente, B., Feve, B., Fellahi, S., & Bastard, J.-P. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.09.004 · Cited by 737
Physiological and pathophysiological roles of NAMPT and NAD metabolism.
Garten, A., Schuster, S., Penke, M., Gorski, T., de Giorgis, T., & Kiess, W. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.117 · Cited by 708
NAD+ metabolism, stemness, the immune response, and cancer
Navas, L. E., & Carnero, A. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00354-w · Cited by 517
Insulin resistance in chronic kidney disease: a systematic review
Spoto, B., Pisano, A., & Zoccali, C. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00340.2016 · Cited by 450
Adya, R., Tan, B. K., Punn, A., Chen, J., & Randeva, H. S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm111 · Cited by 437
Inflammation, a Link between Obesity and Cardiovascular Disease
Wang, Z., & Nakayama, T. (2010) · Mediators of Inflammation · doi:10.1155/2010/535918 · Cited by 412
Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications
Zorena, K., Jachimowicz-Duda, O., Ślęzak, D., Robakowska, M., & Mrugacz, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103570 · Cited by 411
Mechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance
Roden, M. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0190 · Cited by 405
Nampt: linking NAD biology, metabolism and cancer
Garten, A., Petzold, S., Körner, A., Imai, S.-I., & Kiess, W. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.10.004 · Cited by 398
Chang, Y., Chang, D., Lin, K., Shin, S., & Lee, Y. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1201 · Cited by 356
Self-citationAdipose tissue, obesity and adipokines: role in cancer promotion
Booth, A., Magnuson, A., Fouts, J., & Foster, M. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0037 · Cited by 329
Stojsavljević, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i48.18070 · Cited by 325
The secretory function of adipocytes in the physiology of white adipose tissue
Wang, P., Mariman, E., Renes, J., & Keijer, J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21386 · Cited by 318
The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals
Revollo, J. R., Grimm, A. A., & Imai, S.-I. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32801b3c8f · Cited by 310
Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity
Luk, T., Malam, Z., & Marshall, J. C. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0807581 · Cited by 302
Pagano, C., Pilon, C., Olivieri, M., Mason, P., Fabris, R., Serra, R., Milan, G., Rossato, M., Federspil, G., & Vettor, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0361 · Cited by 295
Role of adipokines in cardiovascular disease
Mattu, H. S., & Randeva, H. S. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0232 · Cited by 292
The chronobiology, etiology and pathophysiology of obesity
Garaulet, M., Ordovás, J. M., & Madrid, J. A. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.118 · Cited by 281
NAD metabolism: Implications in aging and longevity
Yaku, K., Okabe, K., & Nakagawa, T. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.05.006 · Cited by 269
The release of the adipocytokine visfatin is regulated by glucose and insulin
Haider, D. G., Schaller, G., Kapiotis, S., Maier, C., Luger, A., & Wolzt, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0303-7 · Cited by 258
Sleep duration, cardiovascular disease, and proinflammatory biomarkers
Grandner, M., Sands-Lincoln, Pak, & Garland (2013) · Nature and Science of Sleep · doi:10.2147/nss.s31063 · Cited by 246
Wang, C., Hsu, H., Hung, W., Yu, T., Chen, Y., Chiu, C., Lu, L., Chung, F., Shin, S., & Lee, Y. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03411.x · Cited by 229
Self-citationImplications of altered NAD metabolism in metabolic disorders
Okabe, K., Yaku, K., Tobe, K., & Nakagawa, T. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0527-8 · Cited by 223
Gualillo, O., González-Juanatey, J. R., & Lago, F. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.09.005 · Cited by 193
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2007) · Science · doi:10.1126/science.318.5850.565b · Cited by 150
RetractedRodriguez, A., Catalan, V., Gomez-Ambrosi, J., & Fruhbeck, G. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781039599 · Cited by 133
Santangelo, C., Filesi, C., Varì, R., Scazzocchio, B., Filardi, T., Fogliano, V., D’Archivio, M., Giovannini, C., Lenzi, A., Morano, S., et al. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0506-9 · Cited by 109
Increase in visfatin after weight loss induced by gastroplastic surgery
Krzyzanowska, K., Mittermayer, F., Krugluger, W., Kopp, H. P., & Schernthaner, G. (2006) · Obesity · doi:10.1038/oby.2006.219 · Cited by 71
“Two other studies found increased visfatin levels in subjects with type 2 diabetes and elevated fasting insulin levels (3,11).”
BackgroundEffect of metformin on serum visfatin levels in patients with polycystic ovary syndrome
Ozkaya, M., Cakal, E., Ustun, Y., & Engin-Ustun, Y. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.10.058 · Cited by 67
Mousa, A., Abell, S. K., Shorakae, S., Harrison, C. L., Naderpoor, N., Hiam, D., Moreno‐Asso, A., Stepto, N. K., Teede, H. J., & de Courten, B. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700488 · Cited by 38
Impact of treatment with metformin on adipokines in patients with polycystic ovary syndrome
Tarkun (2010) · PubMed · doi:10.1684/ecn.2010.0217 · Cited by 28
Metadata
- Authors
- Chen, M.-P., Chung, F.-M., Chang, D.-M., Tsai, J. C.-R., Huang, H.-F., Shin, S.-J., & Lee, Y.-J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-01
- Volume
- 91
- Issue
- 1
- Pages
- 295-299
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1989200821
- Cited by
- 660
- References
- 30
- FWCI
- 44.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.